⌘K

Home/Filings/3/0000899243-22-038926

3//SEC Filing

Cystic Fibrosis Foundation 3

Accession 0000899243-22-038926

CIK 0001614067other

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 6:05 AM ET

Size

3.8 KB

Accession

0000899243-22-038926

Insider Transaction Report

Form 3

Period: 2022-12-08

Aridis Pharmaceuticals, Inc.ARDS

Cystic Fibrosis Foundation

10% Owner

Holdings

Common Stock, par value $0.0001 per share
5,168,732

Documents

1 file

3
doc3.xmlPrimary
FORM 3 SUBMISSION

Issuer

Aridis Pharmaceuticals, Inc.

CIK 0001614067

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001957515

Filing Metadata

Form type: 3
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 6:05 AM ET
Size: 3.8 KB

View on SEC.gov